P1.04-002 Tolerability of Osimertinib and Its Impact on Quality of Life in Advanced Non-Small Cell Lung Cancer Patients: The ARPA Study

Autor: Capelletto, E., Pacchiana, M.V., De Luca, E., Reale, M.L., Gianetta, M., Novello, S.
Zdroj: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1972-S1973
Databáze: ScienceDirect